Lisa Klein is currently a Master's student at Technische Universität München, focusing on their thesis titled "Rational Engineering of Aldolases towards improved Tolerance against Aldehydes." Previously, they gained experience as an intern at Clariant in the field of molecular biotechnology and served as a student associate in various roles at the university. From 2021 to 2024, Lisa held the position of Global Patient Engagement Manager at Trials24 GmbH, which was acquired by SubjectWell, where they now serve as Director of Customer Success for Europe. They hold a Bachelor of Science and a Master of Science in Molecular Biotechnology from Technische Universität München.
This person is not in the org chart
This person is not in any teams
This person is not in any offices